BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 26458742)

  • 1. Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain.
    Takeda S; Wegmann S; Cho H; DeVos SL; Commins C; Roe AD; Nicholls SB; Carlson GA; Pitstick R; Nobuhara CK; Costantino I; Frosch MP; Müller DJ; Irimia D; Hyman BT
    Nat Commun; 2015 Oct; 6():8490. PubMed ID: 26458742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro.
    Nobuhara CK; DeVos SL; Commins C; Wegmann S; Moore BD; Roe AD; Costantino I; Frosch MP; Pitstick R; Carlson GA; Hock C; Nitsch RM; Montrasio F; Grimm J; Cheung AE; Dunah AW; Wittmann M; Bussiere T; Weinreb PH; Hyman BT; Takeda S
    Am J Pathol; 2017 Jun; 187(6):1399-1412. PubMed ID: 28408124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative propagation of assembled human Tau from Alzheimer's disease brain in microfluidic neuronal cultures.
    Katsikoudi A; Ficulle E; Cavallini A; Sharman G; Guyot A; Zagnoni M; Eastwood BJ; Hutton M; Bose S
    J Biol Chem; 2020 Sep; 295(37):13079-13093. PubMed ID: 32699110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.
    Takeda S; Commins C; DeVos SL; Nobuhara CK; Wegmann S; Roe AD; Costantino I; Fan Z; Nicholls SB; Sherman AE; Trisini Lipsanopoulos AT; Scherzer CR; Carlson GA; Pitstick R; Peskind ER; Raskind MA; Li G; Montine TJ; Frosch MP; Hyman BT
    Ann Neurol; 2016 Sep; 80(3):355-67. PubMed ID: 27351289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Ruan Z; Pathak D; Venkatesan Kalavai S; Yoshii-Kitahara A; Muraoka S; Bhatt N; Takamatsu-Yukawa K; Hu J; Wang Y; Hersh S; Ericsson M; Gorantla S; Gendelman HE; Kayed R; Ikezu S; Luebke JI; Ikezu T
    Brain; 2021 Feb; 144(1):288-309. PubMed ID: 33246331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental evidence for the age dependence of tau protein spread in the brain.
    Wegmann S; Bennett RE; Delorme L; Robbins AB; Hu M; McKenzie D; Kirk MJ; Schiantarelli J; Tunio N; Amaral AC; Fan Z; Nicholls S; Hudry E; Hyman BT
    Sci Adv; 2019 Jun; 5(6):eaaw6404. PubMed ID: 31249873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release and trans-synaptic transmission of Tau via exosomes.
    Wang Y; Balaji V; Kaniyappan S; Krüger L; Irsen S; Tepper K; Chandupatla R; Maetzler W; Schneider A; Mandelkow E; Mandelkow EM
    Mol Neurodegener; 2017 Jan; 12(1):5. PubMed ID: 28086931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of ribosomal protein S6 baseline phosphorylation and effect of tau pathology in the murine brain and human hippocampus.
    Klingebiel M; Dinekov M; Köhler C
    Brain Res; 2017 Mar; 1659():121-135. PubMed ID: 28119058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity.
    Wegmann S; Maury EA; Kirk MJ; Saqran L; Roe A; DeVos SL; Nicholls S; Fan Z; Takeda S; Cagsal-Getkin O; William CM; Spires-Jones TL; Pitstick R; Carlson GA; Pooler AM; Hyman BT
    EMBO J; 2015 Dec; 34(24):3028-41. PubMed ID: 26538322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.
    Li L; Jiang Y; Hu W; Tung YC; Dai C; Chu D; Gong CX; Iqbal K; Liu F
    Mol Neurobiol; 2019 Sep; 56(9):6168-6183. PubMed ID: 30734228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors.
    Takeda S
    Neurosci Res; 2019 Apr; 141():36-42. PubMed ID: 30120962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau.
    Mate De Gerando A; Welikovitch LA; Khasnavis A; Commins C; Glynn C; Chun JE; Perbet R; Hyman BT
    Acta Neuropathol; 2023 Aug; 146(2):191-210. PubMed ID: 37341831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internalization of the Extracellular Full-Length Tau Inside Neuro2A and Cortical Cells Is Enhanced by Phosphorylation.
    Wauters M; Wattiez R; Ris L
    Biomolecules; 2016 Aug; 6(3):. PubMed ID: 27548242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice.
    Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA
    Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
    Wu R; Gu J; Zhou D; Tung YC; Jin N; Chu D; Hu W; Wegiel J; Gong CX; Iqbal K; Liu F
    J Alzheimers Dis; 2021; 79(4):1647-1659. PubMed ID: 33459649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.